Science ❯ Medical Research ❯ Clinical Studies
HIV Prevention GLP-1 Agonists Semaglutide Studies Patient Outcomes
Twice-yearly injectable drug outperforms daily Truvada pill in major clinical trials, but high cost raises accessibility concerns.